Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
2.35x
Syngene's operating cash flow exceeded net income in FY 2025, indicating earnings are backed by actual cash generation.
Free Cash Flow
₹4.07B
Syngene's free cash flow was ₹4.07B in FY 2025, down 26.0% from FY 2024.
Dividend Coverage
8.1x
Syngene's free cash flow covered dividends 8.1x in FY 2025, leaving room for reinvestment or debt reduction.
CapEx Intensity
65.1%
Capital expenditure consumed 65.1% of operating cash flow in FY 2025 for Syngene, typical of capital-intensive industries.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 5.10B | 4.96B | |
| Cash flow Operating Activities | 10.42B | 11.68B | |
| Investments in PPE | -4.92B | -7.60B | |
| Cash flow Investing Activities | -4.96B | -7.45B | |
| Dividend Paid | -503.00M | -503.00M | |
| Cash flow Financing Activities | -5.51B | -1.42B | |
| Cash at beginning of period | 895.00M | 857.00M | |
| Cash at end of period | 857.00M | 3.67B | |
| Free Cash Flow | 5.50B | 4.07B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025